This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The inaugural cohort marks an important milestone in the NJEDA’s commitment to fostering innovation and supporting business ventures in their critical early stages. By supporting these 10 new, cutting-edge companies, New Jersey is firmly cementing itself as a national leader in innovation.” million in bonus grant funding.
startup that offers personalized digitaltherapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Existing investors in the April 2020-founded business also joined in the latest round of financing.
MedRhythms, a Portland, Maine-based digitaltherapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digitaltherapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content